Our findings indicate that the chronic upregulation of insulin signaling through the peripheral IR during diet-induced obesity contributes to the development of hepatic dysfunction, and that targeting the IR in peripheral tissues may be an effective approach to treat NAFLD. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.